Home > Insider Trading > Filing (0001209191-19-012336)

Filing Details

Accession Number:: 0001209191-19-012336
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-21 20:16:28
Reporting Period:: 2019-02-19

Accepted Time:: 2019-02-21 20:16:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
906709	Nektar Therapeutics	NKTR	Pharmaceutical Preparations (2834)	943134940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206869	W Howard Robin	C/O Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco CA 94158	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-02-19	33,333	$7.21	350,924	No	4	M	Direct
Common Stock	Disposition	2019-02-19	33,333	$42.32	317,591	No	4	S	Direct
Common Stock	Disposition	2019-02-19	8,882	$42.39	308,709	No	4	S	Direct
Common Stock	Acquisiton	2019-02-20	33,334	$7.21	342,043	No	4	M	Direct
Common Stock	Disposition	2019-02-20	33,334	$43.20	308,709	No	4	S	Direct
Common Stock	Acquisiton	2019-02-21	33,333	$7.21	342,042	No	4	M	Direct
Common Stock	Disposition	2019-02-21	33,333	$41.01	308,709	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2019-02-19	33,333	$0.00	33,333	$7.21
Common Stock	Common Stock	Disposition	2019-02-20	33,334	$0.00	33,334	$7.21
Common Stock	Common Stock	Disposition	2019-02-21	33,333	$0.00	33,333	$7.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
166,667	2016-02-08	2020-02-07	No	4	M	Direct
133,333	2016-02-08	2020-02-07	No	4	M	Direct
100,000	2016-02-08	2020-02-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	410	Indirect	by spouse

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.
This transaction was executed in multiple trades at prices ranging from $41.87 to $42.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $42.82 to $44.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $40.24 to $42.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.